U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Cover of Value of the Periodic Health Evaluation

Value of the Periodic Health Evaluation

Evidence Reports/Technology Assessments, No. 136

, MD, MPH, , BA, , MSc, , MD, MPH, , MD, , MD, , MD, MBA, , MD, , MD, MPH, , MD, MPH, , MD, MPH, MBA, and , MD, MHS, Investigators.

Rockville (MD): Agency for Healthcare Research and Quality (US); .
Report No.: 06-E011

Structured Abstract

Objective:

To systematically review evidence on definitions of the periodic health evaluation (PHE), its associated benefits and harms, and system-level interventions to improve its delivery.

Data Sources:

Electronic searches in MEDLINE®, and other databases; hand searching of 24 journals and bibliographies through February 2006.

Review Methods:

Paired investigators abstracted data and judged study quality using standard criteria. We reported effect sizes for mean differences and proportions in randomized controlled trials (RCTs). We adapted GRADE Working Group criteria to assess quantity, quality and consistency of the best evidence pertaining to each outcome, assigning grades of “high,” “medium,” “low,” or “very low.”

Results:

Among 36 identified studies (11 RCTs), definitions of the PHE varied widely. In studies assessing benefits, the PHE consistently improved (over usual care) the delivery/receipt of the gynecological exam/Pap smear (2 RCTs, small effect (Cohen's d (95% confidence interval (CI)): 0.07 (0.07,0.07)) to large effect (Cohen's d (CI): 1.71 (1.69, 1.73)), strength and consistency graded “high”); cholesterol screening (1 RCT, small effect (Cohen's d (CI): 0.02 (0.00,0.04)) with large associations in 4 observational studies, graded “medium”); and fecal occult blood testing (2 RCTs, large effects (Cohen's d (CI): 1.19 (1.17, 1.21) and 1.07 (1.05, 1.08)), graded “high”). Effects of the PHE were mixed among studies assessing delivery/receipt of counseling (graded “low”), immunizations (graded “medium”) and mammography (graded “low”). In one RCT, the PHE led to a smaller increase in patient “worry” (13%) compared to usual care (23%) (graded “medium”). The PHE had mixed effects on serum cholesterol (graded “low”), blood pressure, body mass index, disease detection, health habits and health status (graded “medium”). The PHE had mixed effects on hospitalization (graded “high”) costs, disability, and mortality (graded “medium”). No studies assessed harms. Delivery of the PHE was improved by scheduling of appointments for PHE (1 RCT, medium effects (Cohen's d (CI): 0.69 (0.68, 0.70)) and offering a free PHE (1 non-RCT, 22% increase) (graded “medium”).

Conclusions:

The evidence suggests delivery of some recommended preventive services are improved by the PHE and may be more directly affected by the PHE than intermediate or long-term clinical outcomes and costs. Descriptions of the PHE and outcomes were heterogeneous, and some trials were performed before dissemination of guidelines by the U.S. Preventive Services Task Force, limiting interpretations of findings. Efforts are needed to clarify the long-term benefits of receiving multiple preventive services in the context of the PHE. Future studies assessing the PHE should incorporate diverse populations, carefully define comparisons to “usual care,” and comprehensively assess intermediate outcomes, harms, and costs.

Contents

Prepared for: Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.1 Contract No. 290-02-0018. Prepared by: The Johns Hopkins University Evidence-based Practice Center, Baltimore, MD.

Suggested citation:

Boulware LE, Barnes GJ, Wilson RF, Phillips K, Maynor K, Hwang C, Marinopoulos S, Merenstein D, Richardson-McKenzie P, Bass EB, Powe NR, Daumit GL. Value of the Periodic Health Evaluation. Evidence Report/Technology Assessment No. 136. (Prepared by The Johns Hopkins University Evidence-based Practice Center under Contract No. 290-02-0018). AHRQ Publication No. 06-E011. Rockville, MD: Agency for Healthcare Research and Quality.

This report is based on research conducted by the Johns Hopkins University Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290-02-0018).The findings and conclusions in this document are those of the author(s), who are responsible for its content, and do not necessarily represent the views of AHRQ. No statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services.

The information in this report is intended to help clinicians, employers, policymakers, and others make informed decisions about the provision of health care services. This report is intended as a reference and not as a substitute for clinical judgment.

This report may be used, in whole or in part, as the basis for the development of clinical practice guidelines and other quality enhancement tools, or as a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied.

The investigators have no relevant financial interests in the report. The investigators have no employment, consultancies, honoraria, or stock ownership or options, or royalties from any organization or entity with a financial interest or financial conflict with the subject matter discussed in the report.

1

540 Gaither Road, Rockville, MD 20850. www​.ahrq.gov

Bookshelf ID: NBK38044

Views

  • PubReader
  • Print View
  • Cite this Page

Similar articles in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...